Mayflower Financial Advisors, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1852930
BOSTON, MA
Position in VRTX
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$835,003
+$53,112 QoQ
Shares Held
1,681
-4.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#910
of 1,744 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mayflower Financial Advisors, LLC holds $1,390,659 across 8 Biotechnology names. VRTX ranks #1 (60.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,681 | $835,003 | |
| 2 | GLUE |
Monte Rosa Therapeutics, Inc.
|
10,000 | $242,000 | |
| 3 | IBRX |
ImmunityBio, Inc.
|
20,212 | $176,956 | |
| 4 | HELP |
Cybin Inc.
|
10,290 | $68,016 | |
| 5 | ELTX |
Elicio Therapeutics, Inc.
|
10,000 | $39,100 | |
| 6 | INO |
Inovio Pharmaceuticals, Inc.
|
12,559 | $13,814 | |
| 7 | GNPX |
Genprex, Inc.
|
909 | $10,380 | |
| 8 | GTBP |
GT Biopharma, Inc.
|
11,000 | $5,390 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $835,003 | 1,681 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $781,891 | 1,751 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $638,330 | 1,408 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $490,724 | 1,253 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $629,067 | 1,413 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $722,866 | 1,491 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $596,398 | 1,481 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $689,248 | 1,482 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,369,153 | 729,312 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,227,466 | 729,139 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,203,192 | 729,112 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,142,102 | 729,135 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,296,631 | 729,560 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,235,522 | 729,555 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $1,169,200 | 729,472 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $1,224,000 | 729,658 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $1,140,000 | 950,675 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,118,000 | 950,643 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $664,000 | 560,062 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $601,000 | 559,811 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $602,000 | 559,797 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $618,000 | 559,857 | Shares | Sole | 2021-04-23 | |
| No filing history on record for this holder in this stock. | ||||||